Loading...
Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe
BACKGROUND: The reimbursement of orphan drugs (OD) is an increasingly important for country policymakers, and still insufficiently understood, especially in Central and Eastern Europe. The aim of this research was to provide a comprehensive description of country-specific health technology assessmen...
Na minha lista:
| Udgivet i: | Orphanet J Rare Dis |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7545889/ https://ncbi.nlm.nih.gov/pubmed/33032634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-020-01556-9 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|